Nikitina E G, Urazova L N, Stegny V N
Cancer Research Institute, Siberian Branch of the Russian Academy of Medical Sciences, Tomsk, Russia.
Exp Oncol. 2012;34(1):2-8.
MicroRNAs (miRNAs) are a recently discovered family of short non-coding RNA molecules of about 19-24 nucleotides in length that are involved in regulation of gene expression. These small molecules have been found to regulate genes involved in diverse biological processes such as cell proliferation, development, differentiation, apoptosis and others. MiRNAs regulate gene expression at the post-transcriptional level either by inhibition of the target (mRNA) or by its destruction. Recent studies have shown that mRNA deregulation is a basic problem in studying pathogenesis of many malignant tumors. It has been recently shown that miRNAs are able to regulate thousands of target genes simultaneously. Thus, the key role of miRNA in carcinogenesis reveals a new layer in the molecular architecture of cancer. Patterns of altered miRNA expression in cancer may serve as molecular biomarkers for tumor diagnosis, prognosis of disease-specific outcomes, and prediction of therapeutic responses. Furthermore, miRNAs may serve as specific targets of new gene therapies.
微小RNA(miRNA)是最近发现的一类短链非编码RNA分子,长度约为19 - 24个核苷酸,参与基因表达的调控。这些小分子已被发现可调控参与多种生物学过程的基因,如细胞增殖、发育、分化、凋亡等。miRNA通过抑制靶标(mRNA)或使其降解在转录后水平调控基因表达。最近的研究表明,mRNA失调是许多恶性肿瘤发病机制研究中的一个基本问题。最近还发现,miRNA能够同时调控数千个靶基因。因此,miRNA在致癌过程中的关键作用揭示了癌症分子结构的一个新层面。癌症中miRNA表达改变的模式可作为肿瘤诊断、疾病特异性结局预后以及治疗反应预测的分子生物标志物。此外,miRNA可能成为新基因治疗的特定靶点。